Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$319M |
| 2 |
Microsoft
MSFT
|
+$286M |
| 3 |
CME Group
CME
|
+$282M |
| 4 |
Verizon
VZ
|
+$272M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$232M |
| 2 |
Duke Energy
DUK
|
+$214M |
| 3 |
VeriSign
VRSN
|
+$146M |
| 4 |
GE Aerospace
GE
|
+$103M |
| 5 |
Edison International
EIX
|
+$75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.86% |
| 2 | Financials | 12.21% |
| 3 | Technology | 10.87% |
| 4 | Industrials | 9.97% |
| 5 | Energy | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGNA
126
DELISTED
TEGNA Inc
TGNA
| $99.8M | 0.2% |
5,972,023
+8,220
| +0.1% | +$132K |
|
127
Cenovus Energy
CVE
$55.6B
| $97.2M | 0.2% |
4,714,300
+1,353,900
| +40% | +$31.2M |
|
128
Humana
HUM
$46.7B
| $97.1M | 0.2% |
676,000
| – | – |
|
129
Agios Pharmaceuticals
AGIO
$2.04B
| $96M | 0.2% |
+856,400
| New | +$76.5M |
|
130
Puma Biotechnology
PBYI
$459M
| $95.3M | 0.19% |
+503,700
| New | +$112M |
|
131
Toronto Dominion Bank
TD
$204B
| $95.1M | 0.19% |
1,989,400
| – | – |
|
132
KLA
KLAC
$272B
| $93M | 0.19% |
13,220,000
| – | – |
|
|
TFCFA
133
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $89.1M | 0.18% |
2,320,600
+1,229,600
| +113% | +$43.5M |
|
|
VALE.P
134
DELISTED
Vale S A
VALE.P
| $88.4M | 0.18% |
12,178,800
| – | – |
|
135
Air Products & Chemicals
APD
$67.7B
| $86.8M | 0.18% |
650,340
| – | – |
|
136
lululemon athletica
LULU
$13.7B
| $86.3M | 0.18% |
1,546,100
| – | – |
|
137
Mattel
MAT
$4.19B
| $85.8M | 0.17% |
2,771,947
| – | – |
|
|
LLTC
138
DELISTED
Linear Technology Corp
LLTC
| $85M | 0.17% |
1,863,700
| – | – |
|
|
NVO
139
Novo Nordisk
NVO
$203B
| $84.8M | 0.17% |
4,008,200
+1,640,000
| +69% | +$36.6M |
|
140
Stryker
SYK
$133B
| $84.8M | 0.17% |
899,051
| – | – |
|
141
CMS Energy
CMS
$22B
| $84.4M | 0.17% |
2,430,000
+1,550,000
| +176% | +$50.6M |
|
142
LyondellBasell Industries
LYB
$20.3B
| $79.4M | 0.16% |
1,000,000
| – | – |
|
|
RCPT
143
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $79.3M | 0.16% |
647,400
+471,700
| +268% | +$47.8M |
|
144
Eli Lilly
LLY
$1.09T
| $78.6M | 0.16% |
+1,140,000
| New | +$76.9M |
|
145
American Tower
AMT
$79.4B
| $78.4M | 0.16% |
793,200
+395,000
| +99% | +$38.8M |
|
|
CIE
146
DELISTED
Cobalt International Energy, Inc
CIE
| $78.2M | 0.16% |
586,647
+20,000
| +4% | +$3.04M |
|
147
Colgate-Palmolive
CL
$73.6B
| $78.2M | 0.16% |
1,130,000
| – | – |
|
148
SiriusXM
SIRI
$9.59B
| $74.8M | 0.15% |
2,137,700
| – | – |
|
149
Trip.com Group
TCOM
$28.7B
| $74.1M | 0.15% |
+3,256,000
| New | +$85.3M |
|
|
TIF
150
DELISTED
Tiffany & Co.
TIF
| $73.1M | 0.15% |
684,100
| – | – |
|
Similar funds
Capital International Investors's Q4 2014 Portfolio in Review
As of Q4 2014, Capital International Investors held 259 positions worth $49.1B, up 20% from $41.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Capital International Investors deployed $6.59B of net new capital in Q4 2014, opening 21 new positions and adding to 107 existing holdings. Its largest new stake was Eversource Energy: 3,205,500 shares worth $172M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $232M trimmed.
- Capital International Investors's largest Q4 2014 buy was Eversource Energy: 3,205,500 shares worth $172M.
- Capital International Investors added most to Wells Fargo in Q4 2014, an estimated $319M increase.
- Capital International Investors's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $232M.
- Capital International Investors fully exited Medtronic in Q4 2014, selling an estimated $68.1M.
- Capital International Investors's ten largest holdings make up 20% of its $49.1B portfolio in Q4 2014.
- Capital International Investors opened 21 new positions and closed 12 in Q4 2014.
- Capital International Investors's portfolio value rose 20% quarter-over-quarter to $49.1B.
Based on Capital International Investors's 13F filing for Q4 2014, filed 13 Feb 2015.